{
  "trial_id": "NCT04154904",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, duration of type 1 diabetes, current use of insulin pump, A1C level, physical activity level, history of severe hypoglycemia, cardiovascular disease history, renal function (GFR), liver function, hematocrit level, adrenal function, infection status, substance abuse history, seizure history, foot ulceration status, peripheral arterial disease status, recent major surgery, use of investigational drugs, immunosuppressive medication use, bleeding disorder status, corticosteroid use, presence of life-threatening diseases, use of glucose-lowering medications other than insulin, blood pressure medication use, chest discomfort with physical activity, overall health status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "duration of type 1 diabetes",
        "current use of insulin pump",
        "A1C level",
        "physical activity level",
        "history of severe hypoglycemia",
        "cardiovascular disease history",
        "renal function (GFR)",
        "liver function",
        "hematocrit level",
        "adrenal function",
        "infection status",
        "substance abuse history",
        "seizure history",
        "foot ulceration status",
        "peripheral arterial disease status",
        "recent major surgery",
        "use of investigational drugs",
        "immunosuppressive medication use",
        "bleeding disorder status",
        "corticosteroid use",
        "presence of life-threatening diseases",
        "use of glucose-lowering medications other than insulin",
        "blood pressure medication use",
        "chest discomfort with physical activity",
        "overall health status"
      ]
    },
    "processed-gen-response": "Age, gender, duration of type 1 diabetes, current use of insulin pump, A1C level, physical activity level, history of severe hypoglycemia, cardiovascular disease history, renal function (GFR), liver function, hematocrit level, adrenal function, infection status, substance abuse history, seizure history, foot ulceration status, peripheral arterial disease status, recent major surgery, use of investigational drugs, immunosuppressive medication use, bleeding disorder status, corticosteroid use, presence of life-threatening diseases, use of glucose-lowering medications other than insulin, blood pressure medication use, chest discomfort with physical activity, overall health status."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Duration of Diabetes, Baseline HbA1c, Insulin Pump Use Duration, Daily Insulin Dose, Physical Activity Level,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Duration of Diabetes",
        "Baseline HbA1c",
        "Insulin Pump Use Duration",
        "Daily Insulin Dose",
        "Physical Activity Level"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Duration of Diabetes, Baseline HbA1c, Insulin Pump Use Duration, Daily Insulin Dose, Physical Activity Level"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Diabetes Duration, Insulin Pump Usage, A1C, BMI, Systolic Blood Pressure, Diastolic Blood Pressure, Hematocrit, Physical Activity Level,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "Diabetes Duration",
        "Insulin Pump Usage",
        "A1C",
        "BMI",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Hematocrit",
        "Physical Activity Level"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Diabetes Duration, Insulin Pump Usage, A1C, BMI, Systolic Blood Pressure, Diastolic Blood Pressure, Hematocrit, Physical Activity Level"
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, duration of type 1 diabetes, A1C, insulin pump usage duration, physical activity level, body mass index (BMI), hematocrit, renal function (GFR), liver function, cardiovascular disease history, seizure disorder history, peripheral arterial disease history, foot ulceration history, medication usage (including beta blockers, non-dihydropyridine calcium channel blockers, corticosteroids, and immunosuppressive medications).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "duration of type 1 diabetes",
        "A1C",
        "insulin pump usage duration",
        "physical activity level",
        "body mass index (BMI)",
        "hematocrit",
        "renal function (GFR)",
        "liver function",
        "cardiovascular disease history",
        "seizure disorder history",
        "peripheral arterial disease history",
        "foot ulceration history",
        "medication usage (including beta blockers, non-dihydropyridine calcium channel blockers, corticosteroids, and immunosuppressive medications)"
      ]
    },
    "processed-gen-response": "Age, sex, duration of type 1 diabetes, A1C, insulin pump usage duration, physical activity level, body mass index (BMI), hematocrit, renal function (GFR), liver function, cardiovascular disease history, seizure disorder history, peripheral arterial disease history, foot ulceration history, medication usage (including beta blockers, non-dihydropyridine calcium channel blockers, corticosteroids, and immunosuppressive medications)."
  }
}